Posts
April 18 2017
SkyPeople Fruit Juice, Inc. announced the closing of their Registered Direct offering in the amount of $2,672,500. EG&S acted as counsel to the Placement Agent.
April 17 2017
Cytori Therapeutics announced the closing of a confidentially marketed public offering of common stock in the amount of $8.8 million. EG&S acted as counsel to the underwriter, Maxim Group LLC.
April 12 2017
Forum Merger Corporation, a company formed for the purpose of entering into a merger, share exchange, asset acquisition or other similar business combination with one or more businesses or entities, announced the closing of its initial public offering in the amount of $150,000,000. EG&S acted as counsel to Forum Merger.
April 12 2017
Blink Health announced that it has raised a $90 million Series B equity funding led by 8VC, bringing its total venture capital funding to $165 million. Blink Health is a technology platform that enables consumers to access the medications at affordable prices through over 57,000 pharmacies nationwide. EGS acted as counsel to Blink Health.
April 12 2017
Catalyst Biosciences Inc. announced the closing of their Underwritten offering in the amount of $18,939,000. EG&S acted as counsel to the Underwriter.
April 10 2017
SGOCO Group Ltd. announced the closing of their Registered Direct offering in the amount of $1,000,000. EG&S acted as counsel to the Investor.
April 06 2017
EKSO Bionics Holdings, Inc. announced the closing of their Registered Direct offering in the amount of $11,719,597. EG&S acted as counsel to the Placement Agent.
April 04 2017
ITUS Corporation announced the closing of its rights offering of common shares in the amount of $4,700,000. EG&S acted as counsel to ITUS.